OR WAIT null SECS
April 01, 2008
Most CROs are entering China with expectations that a significant local market opportunity will develop as major pharmaceutical companies establish research development operations there...
March 05, 2008
Another Asian services provider demonstrates the global nature of pharmaceutical outsourcing.
March 02, 2008
CMOs have positive outlook for 2008 but are wary of competitive pressures.
February 02, 2008
February 01, 2008
As globalization of drug development and manufacturing gathered steam in the early part of this decade, many pharmaceutical companies in the newly-favoured regions of Asia, Eastern Europe and Latin America added contract services as adjuncts to their generic API and dosage form businesses. These new units, which in India are known under the unfortunate acronym of CRAMS (contract research and manufacturing services), were opportunistic responses to the growing outsourcing trends. Unfortunately, in many cases, they were not truly strategic commitments to the services business.
January 02, 2008
The traditional pharmaceutical business model is disintegrating, but the new model is not much different.
December 02, 2007
The dynamics of the R&D pipeline could undercut recent CRO and CMO successes.
November 02, 2007
Candid comments from a Big Pharma executive highlight the complexity of contract manufacturing.
October 02, 2007
Could sloppy due diligence practices hurt CMOs and their clients?
September 02, 2007
Contract manufacturers slim down to improve profitability.